Ferritin: Structure, Mechanism, Neuroferritinopathy in Human Body

Authors

  • Zhenjun Kong University of Wisconsin Madison

DOI:

https://doi.org/10.47611/jsr.v11i4.1721

Keywords:

Ferritin, Neuroferritinopathy, Rare Disease

Abstract

When functioning well, ferritin plays a significant role in human body functioning as it helps to store and release iron ions to maintain human body stability. Otherwise, ferritin may fail in storing or release extra highly oxidative iron ions at different brain tissues, resulting in diseases such as neuroferritinopathy. Neuroferritinopathy is caused by gene mutations through two kinds of FTL genes. It can be inherited through genes and is autosomal dominant. Without paying efforts in tackling this diseases, more and more patients will suffer from its symptoms within generations. These symptoms will affect their daily physical movement and even personalities. Because neuroferritinopathy is caused by oxidative damage, anti-oxidation method therefore might be effective. Inheritance can be prevented by utilizing DNA polymerase or mismatch excision prepare enzymes for eggs and sperms.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References or Bibliography

Reference

BAI Yu-fei, ZHANG Tuo, LI Mei-liang, ZHAO Guang-hua. Research progress in mechanism of iron release from ferritin, Food and industrial science, 2012, 01(33): 409-412.

Burn, J., & Chinnery, P. F. (2006). Neuroferritinopathy. Seminars in Pediatric Neurology, 13(3), 176–181. https://doi.org/10.1016/j.spen.2006.08.006

Cairo, G., & Recalcati, S. (2007). Iron-regulatory proteins: Molecular biology and pathophysiological implications. Expert Reviews in Molecular Medicine, 9(33), 1–13. https://doi.org/10.1017/s1462399407000531

Chen, P., De Meulenaere, E., Deheyn, D. D., & Bandaru, P. R. (2020). Iron redox pathway revealed in ferritin via electron transfer analysis. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-60640-z

Crompton, D. E., Chinnery, P. F., Fey, C., Curtis, A. R. J., Morris, C. M., Kierstan, J., Burt, A., Young, F., Coulthard, A., Curtis, A., Ince, P. G., Bates, D., Jackson, M. J., & Burn, J. (2002). Neuroferritinopathy: A window on the role of iron In neurodegeneration. Blood Cells, Molecules, and Diseases, 29(3), 522–531. https://doi.org/10.1006/bcmd.2002.0589

Goldsby, R. E., Hays, L. E., Chen, X., Olmsted, E. A., Slayton, W. B., Spangrude, G. J., & Preston, B. D. (2002). Nonlinear partial differential equations and applications: High incidence of epithelial cancers in mice deficient for dna polymerase proofreading. Proceedings of the National Academy of Sciences, 99(24), 15560–15565. https://doi.org/10.1073/pnas.232340999

Konijn, A. M., Glickstein, H., Vaisman, B., Meyron-Holtz, E. G., Slotki, I. N., & Cabantchik, Z. I. (1999). The cellular Labile IRON pool and Intracellular Ferritin in K562 Cells. Blood, 94(6), 2128–2134. https://doi.org/10.1182/blood.v94.6.2128.418k20_2128_2134

Konijn, A. M., Glickstein, H., Vaisman, B., Meyron-Holtz, E. G., Slotki, I. N., & Cabantchik, Z. I. (1999). The cellular Labile IRON pool and Intracellular Ferritin in K562 Cells. Blood, 94(6), 2128–2134. https://doi.org/10.1182/blood.v94.6.2128.418k20_2128_2134

LEVI, S., COZZI, A., & AROSIO, P. (2005). Neuroferritinopathy: A neurodegenerative disorder associated with L-ferritin mutation. Best Practice & Research Clinical Haematology, 18(2), 265–276. https://doi.org/10.1016/j.beha.2004.08.021

LEVI, S., COZZI, A., & AROSIO, P. (2005). Neuroferritinopathy: A neurodegenerative disorder associated with L-ferritin mutation. Best Practice & Research Clinical Haematology, 18(2), 265–276. https://doi.org/10.1016/j.beha.2004.08.021

Müller, T., Büttner, T., Gholipour, A.-F., & Kuhn, W. (2003). Coenzyme q10 supplementation provides mild symptomatic benefit in patients with parkinson's disease. Neuroscience Letters, 341(3), 201–204. https://doi.org/10.1016/s0304-3940(03)00185-x

P, P., C, B., & Richardson. (1998). Function and regulation of transferrin and ferritin. Seminars in hematology. https://pubmed.ncbi.nlm.nih.gov/9460808/.

Schröder, I., Johnson, E., & de Vries, S. (2003). Microbial ferric iron reductases. FEMS Microbiology Reviews, 27(2-3), 427–447. https://doi.org/10.1016/s0168-6445(03)00043-3

U.S. National Library of Medicine. (2020, August 18). Neuroferritinopathy: Medlineplus Genetics. MedlinePlus. https://medlineplus.gov/genetics/condition/neuroferritinopathy/.

Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R., & Zecca, L. (2014). The role of iron in brain ageing and neurodegenerative disorders. The Lancet Neurology, 13(10), 1045–1060. https://doi.org/10.1016/s1474-4422(14)70117-6

Yang, W. (2000). Structure and function of mismatch repair proteins. Mutation Research/DNA Repair, 460(3-4), 245–256. https://doi.org/10.1016/s0921-8777(00)00030-6

Published

03-09-2023

How to Cite

Kong, Z. (2023). Ferritin: Structure, Mechanism, Neuroferritinopathy in Human Body. Journal of Student Research, 11(4). https://doi.org/10.47611/jsr.v11i4.1721

Issue

Section

Research Projects